Skip to main content

Table 1 Baseline patients’ characteristics

From: Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy

Age, years (median, range):

 SpaceOAR

70 (54–78)

p = 0.44

 No-SpaceOAR

66 (56–75)

PSA, ng/ml (median, range):

 SpaceOAR

9.3 (6.6–19)

p = 0.08

 No-SpaceOAR

6.8 (4.2–12.7)

Risk Group (n / %):

(Low/ Favorable Intermediate/Unfavorable Intermediate)

  SpaceOAR

3 (30%) / 4 (40%) / 3 (30%)

 

  No-SpaceOAR

2 (20%) / 6 (60%) / 2 (20%)

 

Androgen deprivation therapy (n / %):

 SpaceOAR

3 (30%)

 

 No-SpaceOAR

2 (20%)

 

Prostate Volume, cc (median, range):

 SpaceOAR

62.5 (49.8–79)

p = 0.23

 No-SpaceOAR

55.5 (29.7–79)

Planning Target Volume, cc (median, range):

 SpaceOAR

118.8 (85.7–150.1) p = 0.17

 

 No-SpaceOAR

110.3 (70.9–145.3)

 

IPSS score (median, range):

 SpaceOAR

7 (0–15)s

p = 0.14

 No-SpaceOAR

5 (0–10)